Literature DB >> 19067994

Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes.

Sumiko Yoshida1, Masashi Hirai, Susumu Suzuki, Shuichi Awata, Yoshitomo Oka.   

Abstract

OBJECTIVES: To identify factors independently associated with depression in Japanese patients with diabetes, after controlling for potential confounding factors.
METHODS: Among 197 outpatients with diabetes, 129 (type 1: 24, type 2: 105) completed a questionnaire concerning socio-demographic and health-related variables. Depression screening was done using Zung's Self-Rating Depression Scale test, followed by diagnostic interviews by experienced psychiatrists employing the Diagnostic Statistical Manual of Mental Disorders, 4th edition (DSM-IV).
RESULTS: Forty-seven patients (36.4%) had symptomatological depression. A Self-Rating Depression Scale cut-off score of 40 had good sensitivity (100%) and modest specificity (59%) for detecting major depressive episode, in accordance with the DSM-IV. Diabetic patients suffering from depression were more likely to have neuropathy, retinopathy, body pain, a feeling of poor general health, and lack of social support, than the non-depressed patients. However, age, gender, marital status, diabetes type, insulin requirement, duration of diabetes, hemoglobin A1c (HbA1c) and the presence of nephropathy did not differ between the two groups. In multivariate logistic regression analysis, body pain (OR 3.26, 95% CI 1.31-8.08) and the presence of microvascular complications (OR 2.81, 95% CI 1.13-6.98) were independent factors associated with depression. Specifically, diabetic neuropathy (OR 3.10, 95% CI 1.17-8.22) was associated with depression independently of age, gender, marital status, social supports, quality of life, diabetes type, duration of diabetes, HbA1c, and insulin requirement.
CONCLUSIONS: A diabetic complication, specifically neuropathy, was independently associated with depression in patients with diabetes. The present findings indicate the need to find a biological base common to both depression in diabetes and diabetic neuropathy.

Entities:  

Mesh:

Year:  2008        PMID: 19067994     DOI: 10.1111/j.1440-1819.2008.01889.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  15 in total

1.  Relationship between retinopathy severity, visual impairment and depression in persons with long-term type 1 diabetes.

Authors:  Flavio E Hirai; James M Tielsch; Barbara E K Klein; Ronald Klein
Journal:  Ophthalmic Epidemiol       Date:  2012-08       Impact factor: 1.648

Review 2.  Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators.

Authors:  Rakesh Jain; Shailesh Jain; Charles L Raison; Vladimir Maletic
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

3.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

4.  Quality of life and emotional change for middle-aged and elderly patients with diabetic retinopathy.

Authors:  Yao Yu; Lie Feng; Yi Shao; Ping Tu; He-Ping Wu; Xun Ding; Wei-Hua Xiao
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

5.  Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and health-related quality of life in haemodialysis patients.

Authors:  Huseyin Atalay; Yalcin Solak; Zeynep Biyik; Abduzhappar Gaipov; Figen Guney; Suleyman Turk
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

6.  Coffee consumption is inversely associated with depressive status in Japanese patients with type 2 diabetes.

Authors:  Katsuhisa Omagari; Mika Sakaki; Yuki Tsujimoto; Yukiko Shiogama; Akiko Iwanaga; Makiko Ishimoto; Asami Yamaguchi; Miki Masuzumi; Miku Kawase; Mayuko Ichimura; Takatoshi Yoshitake; Yoshiyuki Miyahara
Journal:  J Clin Biochem Nutr       Date:  2014-07-31       Impact factor: 3.114

7.  Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania.

Authors:  Aldona Mikaliūkštienė; Kęstutis Žagminas; Algirdas Juozulynas; Laura Narkauskaitė; Jonas Sąlyga; Konstancija Jankauskienė; Rimantas Stukas; Genė Šurkienė
Journal:  Med Sci Monit       Date:  2014-02-04

8.  Investigation of depression in Greek patients with diabetic peripheral neuropathy.

Authors:  Maria Rekleiti; Pavlos Sarafis; Maria Saridi; Aikaterini Toska; Chrysovaladis Melos; Kyriakos Souliotis; Maria Tsironi
Journal:  Glob J Health Sci       Date:  2013-06-16

Review 9.  Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele M Giusti; Gian Mauro Manzoni; Donatella Saviola; Arianna Gatti; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara A M Spatola; Stefania Corti; Margherita Novelli; Valentina Villa; Andrea Cottini; Carlo Lai; Francesco Pagnini; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Paolo Capodaglio; Guido E D'Aniello; Federica Scarpina; Andrea Brioschi; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan G Simpson; Brenda Wiederhold; Stefano Tamburin
Journal:  Front Psychol       Date:  2016-04-19

10.  Occurrence and Predictors of Depression and Poor Quality of Life among Patients with Type-2 Diabetes: A Northern India Perspective.

Authors:  Prerna Bahety; Gunjan Agarwal; Deepak Khandelwal; Deep Dutta; Sanjay Kalra; Pankaj Taparia; Vikas Singhal
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.